In outpatients with mild to moderate COVID-19, low-dose fluvoxamine did not reduce time to sustained recovery

Author(s):

Jeremy Clark, Steven Y.C. Tong

Details:

Annals of Internal Medicine, Volume 176, Issue 5, 2023-05-01

Article Link: Click here

Affiliations: